Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07362303 · ClinicalTrials.gov registry record · NA
Neuralert Stroke Monitor Trial
A NA study, sponsored by Neuralert Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
NCT07362303: Recruiting NA study, sponsored by Neuralert Technologies.
NCT07362303 is a NA study that is actively recruiting participants, run by Neuralert Technologies. The registered enrollment target is 1,200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07362303, a NA study, is actively recruiting participants, sponsored by Neuralert Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
The Neuralert monitoring system, a non-invasive device worn on each wrist, is designed to provide continuous monitoring and expedited recognition of stroke by identifying asymmetry in the extremities, facilitating patient treatment and improving outcomes. This study is designed to evaluate the safety and effectiveness of the Neuralert Monitor. This study aims to show that the device produces fewer than 2 false alarms per patient per day on average, and that the device detects stroke with a sensitivity significantly greater than a device producing 2 random alerts per day.
Primary Outcome
To show that the sensitivity of the Neuralert Monitor exceeds the specified performance goal, and
Interventions
- DEVICE Neuralert Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2026-03-26 |
| Est. Completion | 2028-07-15 |
| Phase | NA |
What NCT07362303 shows while recruiting
NCT07362303 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 1 intervention - of which Neuralert Monitor is the first listed.
NCT07362303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07362303 about?
NCT07362303 is a clinical study titled "Neuralert Stroke Monitor Trial". The Neuralert monitoring system, a non-invasive device worn on each wrist, is designed to provide continuous monitoring and expedited recognition of stroke by identifying asymmetry in the extremities, facilitating patient treatment and improving outcomes. This study is designed to evaluate the safet...
What is the current status of trial NCT07362303?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2026-03-26. Estimated completion is 2028-07-15.
What interventions are being tested in trial NCT07362303?
The interventions under investigation include: Neuralert Monitor (DEVICE).
Who is sponsoring clinical trial NCT07362303?
This trial is sponsored by Neuralert Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07362303's enrollment target sits among peer trials
1,200 83rd of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI